Strong

Our patients don’t just live with diabetes, they thrive with diabetes.

Leading

We’re constantly pushing forward toward the next great discovery.

Joslin and COVID-19

At Joslin Diabetes we are committed to providing the very best and safest care possible. In response to the COVID-19 pandemic, Joslin has shifted to a remote model of care for our patients. Our remote care model with limited, in-person “urgent care” appointments means: In-clinic appointments are limited to very urgent appointments which must be authorized by the Joslin provider. Patients should...
Joslin's Response to Covid-19

Protecting beta cells against stress may guard against type 1 diabetes

An existing drug boosts survival for insulin-producing cells under autoimmune attack. BOSTON – (July 27, 2020) – Type 1 diabetes occurs when a person’s own immune system destroys insulin-producing...
Read more on Protecting beta cells against stress may guard against type 1 diabetes

Dr. Jennifer K. Sun promoted to Senior Investigator at Joslin Diabetes Center

Dr. Jennifer K. Sun, MD, MPH has been promoted to Senior Investigator within the Research Section of the Joslin Diabetes Center. This prestigious appointment recognizes sustained excellence in...
Read more on Dr. Jennifer K. Sun promoted to Senior Investigator at Joslin Diabetes Center

Cinnamon linked to blood sugar control in prediabetes, study finds

Cinnamon may improve blood sugar control in people with a condition known as prediabetes and may slow the progression to type 2 diabetes, according to a new pilot study of 51 people with elevated...
Read more on Cinnamon linked to blood sugar control in prediabetes, study finds

Joslin and COVID-19

At Joslin Diabetes we are committed to providing the very best and safest care possible. In response to the COVID-19 pandemic, Joslin has shifted to a remote model of care for our patients. Our remote care model with limited, in-person “urgent care” appointments means: In-clinic appointments are limited to very urgent appointments which must be authorized by the Joslin provider. Patients should...
Joslin's Response to Covid-19

Protecting beta cells against stress may guard against type 1 diabetes

An existing drug boosts survival for insulin-producing cells under autoimmune attack. BOSTON – (July 27, 2020) – Type 1 diabetes occurs when a person’s own immune system destroys insulin-producing...
Read more on Protecting beta cells against stress may guard against type 1 diabetes

Promising treatment to slow kidney disease doesn’t prove out in clinical trial

Scientists find that reducing levels of uric acid in the blood does not guard against complication in type 1 diabetes. BOSTON – (June 25, 2020) – Historically, half or more of people with type 1...
Read more on Promising treatment to slow kidney disease doesn’t prove out in clinical trial